Within a cohort of 30 patients with type 2 diabetes requiring multiple oral anti-hyperglycemic drugs plus high-dose insulin, Bhansaliet al. showed a significant reduction in insulin requirement after the infusion of BM-derived MSCs compared with patients receiving placebo90. Here, INS is linked to type 2 diabetes mellitus.